OTC · Biotechnology

Kane Biotech Inc. (KNBIF) Stock

$0.02 +0.00% OTC: KNBIF Healthcare

Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms.

Valuation

MetricValue
Price$0.02
Market Cap$4.13M
P/E Ratio-1.98
P/B Ratio-3.21
P/S Ratio87.52
EPS (TTM)$-0.02
52-Week High$0.04
52-Week Low$0.01
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE277.77%
ROA-122.46%
ROCE337.01%
Gross Margin-390.49%
Operating Margin-1557.92%
Net Margin0.00%
Debt/Equity-1.35
Current Ratio0.45

Annual Financials (USD)

Metric20212022202320242025
Revenue$2.0M$3.0M$0$2.0M$0
Operating Profit$-5.0M$-3.0M$-3.0M$-4.0M$-3.0M
Net Profit$-5.0M$-4.0M$-5.0M$6.0M$-3.0M
EPS$-0.04$-0.03$-0.04$-0.02$-0.02
Op Margin-303.8%-129.6%-2253.6%-188.5%-727.4%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$6.0M$6.0M$6.0M$2.0M$3.0M
Total Liabilities$8.0M$10.0M$14.0M$4.0M$3.0M
Cash$1.0M$1.0M$1.0M$0$1.0M
Borrowings$5.0M$7.0M$9.0M$2.0M$2.0M

Latest News

Kane Biotech Announces Results of Annual and Special Meeting of Shareholders GlobeNewswire · Jul 2, 2026 Kane Biotech Announces Grant of Stock Options GlobeNewswire · May 29, 2026 Kane Biotech Announces First Quarter 2026 Financial Results GlobeNewswire · May 28, 2026 Kane Biotech Raises $1.16 Million in a Private Placement Offering of Share Units MT Newswires · May 26, 2026 Kane Biotech Announces the Oversubscription and Closing of Private Placement Offering GlobeNewswire · May 26, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-2.0M$-3.0M$-3.0M$-4.0M$-3.0M
Investing Cash Flow$-1.0M$0$0$10.0M$0
Financing Cash Flow$2.0M$0$3.0M$-1.0M$0
Net Cash Flow$0$0$0$-2.0M$1.0M
Free Cash Flow$-3.0M$-3.0M$-3.0M$-4.0M$-3.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.02
EV / EBITDA-2.66
FCF Yield-50.92%
Quick Ratio0.27
Interest Coverage-10.86
Return 1Y-30.48%
Return 3Y-69.75%
Return 5Y—

Ownership

Insiders Held39.85%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIXTBioxytran, Inc. $0.02 +1.49% -0.91 $2.37M 0.00%
BUDZWEED, Inc. $0.02 -10.69% -2.35 $2.97M 0.00%
BVAXFBioVaxys Technology Corp. $0.11 +0.09% -0.59 $3.27M 0.00%
BZYRBurzynski Research Institute, Inc. $0.00 — -0.41 $525794 0.00%
FAMDFFutura Medical plc $0.00 — -0.15 $712597 0.00%

About Kane Biotech Inc.

Kane Biotech Inc. is a biotechnology firm specializing in the research, development, and global commercialization of innovative technologies and products focused on preventing and eradicating microbial biofilms. The company's diverse product lineup includes pet dental care solutions under the StrixNB and bluestem brands, as well as DispersinB for treating wounds in both animals and humans. They also manufacture Alosera shampoos for dogs, cats, and horses, and Aledex coatings for medical devices. Additionally, Kane Biotech provides DermaKB products for scalp health, Coactiv+ for wound management, and other offerings such as goldstem, silkstem, and DermaKB Biofilm. Founded in 2001, Kane Biotech Inc. is headquartered in Winnipeg, Canada.

Kane Biotech Inc. is headquartered in CA.

Kane Biotech Inc. (KNBIF) stock trades at $0.02 with a market capitalization of $4.13M. The stock is valued at a price-to-earnings (P/E) ratio of -1.98, price-to-book of -3.21, price-to-sales of 87.52. Over the past 52 weeks the stock has ranged between $0.01 and $0.04, and currently trades 50.0% below its 52-week high.

On profitability, Kane Biotech Inc. generates a return on equity (ROE) of 277.77% — well above the market average, a sign of a high-quality business, return on capital employed of 337.01%, an operating margin of -1557.92%, a net profit margin of 0.00%.

Official website: kanebiotech.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides